Dose‐dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori‐positive patients

BACKGROUND: Gastric intestinal metaplasia is a pre‐cancerous condition associated with multiple factors. OBJECTIVE: We evaluated whether cumulative proton pump inhibitor dose is associated with the diagnosis of gastric intestinal metaplasia while controlling for multiple variables. METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Snir, Yifat, Leibovitzh, Haim, Leibovici‐Weissman, Yaara, Vilkin, Alex, Cohen, Arnon D., Shochat, Tzippy, Niv, Yaron, Dotan, Iris, Feldhamer, Ilan, Boltin, Doron, Levi, Zohar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Neurogastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259238/
https://www.ncbi.nlm.nih.gov/pubmed/32962566
http://dx.doi.org/10.1177/2050640620951403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259238/
https://www.ncbi.nlm.nih.gov/pubmed/32962566
http://dx.doi.org/10.1177/2050640620951403

Ejemplares similares